Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer
- 31 October 1993
- journal article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 166 (4), 389-394
- https://doi.org/10.1016/s0002-9610(05)80339-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing MiceScience, 1992
- Head and Neck Squamous Cell Carcinoma Cell Line‐Induced Suppression of in vitro Lymphocyte Proliferative ResponsesOtolaryngology -- Head and Neck Surgery, 1992
- Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alphaThe American Journal of Surgery, 1991
- Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neckThe American Journal of Surgery, 1989
- Immunologic determinants of head and neck cancer response to induction chemotherapy.Journal of Clinical Oncology, 1989
- Indomethacin sensitive suppressor-cell activity in head and neck cancer patients: The role of the adherent mononuclear cellCancer, 1988
- Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neckCancer, 1986
- Definite vs Adjuvant Radiotherapy: Comparative Effects on Lymphocyte Subpopulations in Patients With Head and Neck Squamous CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1985
- Immunologic evaluation and prognosis in patients with head and neck cancerThe American Journal of Surgery, 1977
- T-cell deficiency in patients with squamous cell cancer of the head and neckThe American Journal of Surgery, 1975